期刊文献+

CD80/IgG融合基因重组表达载体的构建及在CHO细胞中功能性表达的研究

Construction of CD80/IgG recombinant vector and investigation on its functionally expressing in CHO cells
原文传递
导出
摘要 目的构建CD80/IgG真核表达载体,使其在中国地仓鼠卵巢细胞(Chinesehamsterovum,CHO)中功能性表达,寻找消除白血病细胞免疫逃逸的有效方法。方法采用定向分子克隆技术将小鼠CD80胞外段和IgG1Fc段的cDNA串联至真核表达载体pcDNA3.0中,运用脂质体将所得的重组子转染CHO细胞,经免疫印迹、斑点ELISA检测其表达,免疫亲和层析法纯化其表达产物,用流式细胞术、MTT比色法及ELISA在体外检测该产物的生物学活性。结果两段目的基因按预期设想克隆入空载体中并得到了表达,亲和层析纯化获得了高纯度目的蛋白,该蛋白能够将白血病细胞表面CD80分子密度提高5倍,并可显著增强同种异体小鼠淋巴细胞的增殖、对白血病细胞的杀伤以及IL-2的分泌。结论成功构建了融合基因真核表达载体,其表达产物在体外具有相应的生物学功能,有希望成为消除白血病细胞免疫逃逸的有力工具。 Objective To construct CD80/IgG recombinant expressing vector and express it in Chinese hamster ovum ceils in order to seek effective methods to eliminate immune escape of leukemic cells . Methods Two cDNAs were amplified by PCR respectively from plasmid pcDNMB7 containing the full-length cDNA of murine CD80 and murine spleen ceils and cloned to the eukaryotic expression vector pcDNA3.0 by direcfionally cloning and the resultant recombinant plasmid pcDNMCD80-IgG was transfected into CHO ceils with liposome tmnsfecfion reagent. The constitutively expressing ceils were obtained by G418 screening. Western blot and Dot ELISA were used to detect the expression of the fusion protein. Expressed fusion protein was purified with affinity chromatography and its biological activity was examined by flow cytometry, MTT colorimetry and ELISA. Results Two inserts were successhflly cloned into the plasmid pcDNA3.0. Highly purified fusion protein was obtained, which was proved that it could significantly upregulate CD80 density on leukemic ceils and deliberately promote the proliferation of mouse allogeneic lymphocytes and their killing rate against WEHI-3 ceils from 49.7% to 84.6% ( P 〈 0.05). ELISA assay showed that the fusion protein could also enhance IL-2 excretion of aUogeneic lymphocytes activated by tumor antigen. Conclusion The recombinant vector was successfully constructed and functionally expressed in animal ceils. This laid the foundation for the consequent investigations on how to efiminate the immune escape of AML ceils.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2005年第9期747-751,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(No.30240022)
  • 相关文献

参考文献6

  • 1Whiteway A, Corbett T, Anderson R, et al. Expression of co-stimulatory molecules on acute myeloid leukemia blasts may effect duration of first remission. Br J Haematol, 2003, 120(3): 442-451.
  • 2Narita M, Takahashi M, Liu A, et al. Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia. Exp Haematol, 2001, 29(6): 709-719.
  • 3金冬雁 黎孟枫 侯云德 译.分子克隆实验指南(第2版)[M].北京:科学出版社,2002.888-897.
  • 4Notter M, Willingor T, Erben U, et al. Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acutemyeloid leukemia blasts increases their costimulatory activity for autologous remission T cells. Blood, 2001,97(15): 3138 -3145.
  • 5Notter M, Ludwig WD, Bremer S, et al. Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferon-inducible high affinity Fc gamma R Ⅰ receptor(CD64) on autologous acute myeloid leukemic blest cells. Blood, 1993, 82(10): 3113-3124.
  • 6Sturmhoefel K, Lee K, Gray GS, et al. Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and es vaccine adjuvant.Cancer Res, 1999, 59(19): 4964-4972.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部